NIH-funded research Fellowship grant

Investigating how a specific gene affects nicotine withdrawal in the brain.

Official title: Role of Dynamic Signaling of NRG3-ErbB4 in the Prefrontal Cortex in Mediating Nicotine Withdrawal Phenotypes

Funded at University of Kentucky · NIH-11015770 · Data updated 2026-11-12

This study is looking at how certain genes in the brain might affect how people feel and behave when they stop using nicotine, with the hope of finding new ways to help people quit smoking.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionUniversity of Kentucky
NIH-funded
Lab location1 site (Lexington, United States)
Project startJanuary 12, 2024
Project endJanuary 11, 2027
Funding year2025
Award (this year)$48,974
NIH project number5F31DA057812-02
Project IDNIH-11015770 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals struggling with nicotine dependence or those interested in smoking cessation.

Less likely to help

Patients who do not smoke or are not interested in quitting smoking may not benefit from this research.

What this research studies

This research focuses on understanding the role of the Neuregulin 3 (NRG3) gene and its receptor ErbB4 in the prefrontal cortex during nicotine withdrawal. By using a genetic mouse model, the study aims to explore how variations in these genes influence behavioral responses to nicotine dependence and withdrawal. The researchers will analyze the specific contributions of ErbB4 to nicotine withdrawal behaviors and examine the molecular changes that occur in the brain during chronic nicotine exposure and withdrawal. This approach could lead to new insights into potential therapies for smoking cessation.

Why it matters

Potential benefit: If successful, this research could lead to the development of more effective treatments for nicotine addiction and improved smoking cessation strategies.

How similar studies have gone: Other research has shown promise in exploring genetic factors related to nicotine dependence, suggesting that this approach could yield valuable insights.

Where this research is happening

  • University of Kentucky
    Lexington, United States
    Active

Researchers

  • Principal investigator: Prantzalos, Emily — University of Kentucky
  • Study coordinator: Prantzalos, Emily

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.